Caricamento...
Rivastigmine Reduces “Likely to Use Methamphetamine” in Methamphetamine-Dependent Volunteers
We previously reported that treatment with the cholinesterase inhibitor rivastigmine (3 mg, PO for 5 days) significantly attenuated “Desire for METH”. Given that higher dosages of rivastigmine produce greater increases in synaptic ACh, we predicted that 6 mg should have more pronounced effects on cr...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3877939/ https://ncbi.nlm.nih.gov/pubmed/22230648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pnpbp.2011.12.014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|